
NYSEReal EstateREIT - Mortgage
Latest quote
$11.64
+$0.05 · +0.43%
Ellington Financial Inc., operating through its subsidiary, Ellington Financial Operating Partnership LLC, is an investment company primarily focused on acquiring and actively managing a broad range of financial assets within the United States. Its extensive portfolio encompasses various mortgage-related instruments, including residential mortgage-backed securities (RMBS) — both those guaranteed by U.S. government agencies and those backed by non-agency residential loans like prime jumbo, Alt-A, manufactured housing, and subprime mortgages — as well as direct residential and commercial mortgage loans and other commercial real estate debt. The company also invests in consumer loans and asset-backed securities underpinned by consumer and commercial assets. Beyond real estate and consumer finance, Ellington Financial holds corporate debt and equity securities, corporate loans, and collateralized loan obligations. Additionally, it engages with mortgage-related and non-mortgage-related derivatives and pursues other strategic investment opportunities. Founded in 2007, the company's headquarters are located in Old Greenwich, Connecticut.
Latest quote
$11.64
+$0.05 · +0.43%
After-hours
$11.64
$0.00 · 0.00%
Oct 8, 4:01 PM ET
Regular session · ET · Market data may be delayed.
Ellington Financial Inc., operating through its subsidiary, Ellington Financial Operating Partnership LLC, is an investment company primarily focused on acquiring and actively managing a broad range of financial assets within the United States. Its extensive portfolio encompasses various mortgage-related instruments, including residential mortgage-backed securities (RMBS) — both those guaranteed by U.S. government agencies and those backed by non-agency residential loans like prime jumbo, Alt-A, manufactured housing, and subprime mortgages — as well as direct residential and commercial mortgage loans and other commercial real estate debt. The company also invests in consumer loans and asset-backed securities underpinned by consumer and commercial assets. Beyond real estate and consumer finance, Ellington Financial holds corporate debt and equity securities, corporate loans, and collateralized loan obligations. Additionally, it engages with mortgage-related and non-mortgage-related derivatives and pursues other strategic investment opportunities. Founded in 2007, the company's headquarters are located in Old Greenwich, Connecticut.
Day range
Current $11.64
52-week range
Current $11.64
Regular session · ET · Market data may be delayed.
GoAI Score
Buy
Valuation
85
Deep Value
Sentiment
58
Mixed
Risk
17
Low Risk
Momentum
42
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Ellington Financial Inc., operating through its subsidiary, Ellington Financial Operating Partnership LLC, is an investment company primarily focused on acquiring and actively managing a broad range of financial assets within the United States. Its extensive portfolio encompasses various mortgage-related instruments, including residential mortgage-backed securities (RMBS) — both those guaranteed by U.S. government agencies and those backed by non-agency residential loans like prime jumbo, Alt-A, manufactured housing, and subprime mortgages — as well as direct residential and commercial mortgage loans and other commercial real estate debt. The company also invests in consumer loans and asset-backed securities underpinned by consumer and commercial assets. Beyond real estate and consumer finance, Ellington Financial holds corporate debt and equity securities, corporate loans, and collateralized loan obligations. Additionally, it engages with mortgage-related and non-mortgage-related derivatives and pursues other strategic investment opportunities. Founded in 2007, the company's headquarters are located in Old Greenwich, Connecticut.
Day range
Current $11.64
52-week range
Current $11.64
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 674.55M USD | 282.19M USD | 256.5M USD | 43.15M USD | 216.8M USD |
| Cost of goods sold | 106.17M USD | — | — | — | 42.33M USD |
| Gross profit | 568.37M USD | 282.19M USD | 256.5M USD | 43.15M USD | 174.46M USD |
| Selling, general, and administrative | 13.06M USD | 65.69M USD | 68.49M USD | 29M USD | 20.91M USD |
| Operating expenses | 153.08M USD | 165.92M USD | 167.29M USD | 68.12M USD | 39.52M USD |
| Interest income | 494.49M USD | 416.02M USD | 370.17M USD | 140.44M USD | 175.51M USD |
| Interest expense | 304.53M USD | 279.61M USD | 262.45M USD | — | 44.03M USD |
| Depreciation and amortization | — | — | — | 5.67M USD | — |
| Operating income | 415.29M USD | 116.27M USD | 89.21M USD | −24.97M USD | 134.94M USD |
| Net income | 146.87M USD | 145.86M USD | 84.08M USD | −70.05M USD | 133.46M USD |
Company facts updated Oct 8, 2026.
Recent quarterly results
Recent quarterly results
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core S&P Small-Cap ETFIJR89.29M0.09%104.29B USD0.06%$137.31+0.17%
Vanguard Morningstar Total Stock Market ETFVTI50.66M0.00%2.3T USD0.03%$379.56-0.39%
iShares Russell 2000 ETFIWM37.86M0.05%78.56B USD0.19%$277.63-0.03%
iShares Mortgage Real Estate ETFREM21.34M4.70%462.2M USD0.48%$17.56+1.27%
Vanguard Extended Market ETFVXF19.39M0.02%95.4B USD0.05%$233.13-0.15%
VanEck Mortgage REIT Income ETFMORT15.29M4.91%311.5M USD0.43%$7.81+1.30%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM13.89M0.09%16.01B USD0.03%$53.36+0.15%
Global X - SuperDividend ETFSDIV11.07M0.94%1.17B USD0.58%$23.82+1.02%
iShares Core S&P Small-Cap ETFIJR
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
iShares Mortgage Real Estate ETFREM
Vanguard Extended Market ETFVXF
VanEck Mortgage REIT Income ETFMORT
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM
Global X - SuperDividend ETFSDIVAI-generated and delayed market data for informational and educational purposes only. Not investment advice.